Alnylam Pharmaceuticals (ALNY) EBT Margin (2009 - 2026)
Alnylam Pharmaceuticals' EBT Margin was 13.77% in Q2 2026, up 19.11 percentage points from -5.34% a year earlier but down 5.22 percentage points from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) EBT Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Alnylam Pharmaceuticals' EBT Margin was 15.95% through Jun 30, 2026, up 29.65 percentage points year-over-year; for FY2025, it was 8.70%, up 25.49 percentage points from FY2024.
- EBT Margin has now increased for three consecutive years, with a five-year change of +182.30 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was -16.79% in FY2024 (+6.93 pp), -23.71% in FY2023 (+84.92 pp), -108.63% in FY2022 (-7.70 pp) and -100.93% in FY2021 (+72.67 pp).
- Quarterly EBT Margin has moved between -153.59% (Q3 2022) and 22.46% (Q3 2025) over five years.
- Compared with a year earlier, EBT Margin was higher in three of the last six quarters, with an average year-over-year change of +9.50 percentage points.
- The best year-over-year quarter for EBT Margin over five years was Q3 2023 (a gain of 173.67 percentage points); the worst was Q3 2022 (a drop of 44.74 percentage points).
- Per Business Quant data, ALNY's EBT Margin in the three quarters before Q2 2026 was 18.99% (Q1 2026), 7.86% (Q4 2025) and 22.46% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | Alnylam Pharmaceuticals | 20.30 Bn | 7.49 Bn | 1.10 Bn | 20.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 20.29% |
| Jun 30, 2026 | 13.77% |
| Mar 31, 2026 | 18.99% |
| Dec 31, 2025 | 7.86% |
| Sep 30, 2025 | 22.46% |
| Jun 30, 2025 | -5.34% |
| Dec 31, 2024 | -32.70% |
| Sep 30, 2024 | -21.69% |
| Jun 30, 2024 | -1.69% |
| Mar 31, 2024 | -12.86% |
| Dec 31, 2023 | -31.31% |
| Sep 30, 2023 | 20.08% |
| Jun 30, 2023 | -86.03% |
| Mar 31, 2023 | -53.98% |
| Dec 31, 2022 | -61.79% |
| Sep 30, 2022 | -153.59% |
| Jun 30, 2022 | -122.18% |
| Mar 31, 2022 | -112.24% |
| Dec 31, 2021 | -100.68% |
| Sep 30, 2021 | -108.85% |
API Access
Alnylam Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();